Biological and reagent material
Ended Purchase Order Awarded Last action
- Contract number
- 75N91020P00866
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $16,260
Award facts
- Contract value 100% obligated
- $16,260.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Marshallton, DE 19808, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Agilent Technologies Inc. for $16,260.00 on August 31, 2020, for biological and reagent material with a firm fixed price. Place of performance is Marshallton, Delaware, with an ultimate completion date of September 30, 2020. The order was not set-aside and reflects full and open competition.
Quick answers
Who was awarded contract 75N91020P00866?
75N91020P00866 was awarded to Agilent Technologies Inc. by National Cancer Institute (National Institutes of Health) on August 31, 2020.
How much is contract 75N91020P00866 worth?
The government has obligated $16,260 on 75N91020P00866.
Was contract 75N91020P00866 competed?
The extent of competition for 75N91020P00866 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award